相关实验视频

Updated: Jun 15, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

生物信息学分析预测,大麻素可以作为结肠直肠癌中MAPK途径的潜在抑制剂

Julianne du Plessis¹, Aurelie Deroubaix^1,2, Aadilah Omar¹

¹Department of Internal Medicine, Oncology Division, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South Africa.

Current issues in molecular biology

|August 28, 2024

概括

大麻素 (CBD) 可能通过向EGFR和MAPK等关键信号通路来抑制结肠直肠癌 (CRC) 的进展. 这项研究预测CBD是CBD.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

大肠直肠癌 (CRC) 涉及对细胞功能至关重要的信号通路的失调.
大麻素 (CBD) 在体外对CRC细胞系表现出抗癌作用,但其分子点尚不清楚.
皮表皮生长因子受体 (EGFR) 和基激活蛋白激酶 (MAPK) 途径在CRC中经常发生变化.

研究的目的:

研究大麻素 (CBD) 与结直肠癌 (CRC) 信号通路中的关键蛋白质的潜在分子相互作用.
用计算方法预测CBD与目标蛋白相互作用的结合部位和机制.
假设CBD结合这些信号通路的功能后果.

主要方法:

在分析以确定潜在的CBD结合伙伴蛋白.
分子对接模拟用于预测CBD在选定蛋白质上的结合点.
文献审查以假设CBD-蛋白相互作用的功能影响.

主要成果:

预计CBD与表皮生长因子受体 (EGFR),RAS/RAF异型,MEK1/2和ERK1/2.2相互作用.
假设CBD结合发生在这些蛋白质的ATP结合部位或DFG动机.
预计这种相互作用会抑制目标信号蛋白的催化活性.

结论:

通过抑制关键信号通路,CBD可能会在结直肠癌 (CRC) 中发挥其抗癌作用.
预测的抑制机制涉及阻断ATP结合或改变蛋白质构造,从而减少信号传递.
这些发现为CBD在CRC治疗中的潜在治疗作用提供了分子基础.

关键词:

欧洲农业基金会 (EGFR) 是一个基金.这就是MAPKK的意思.拉斯/拉夫 (Ras/Raf) 是一个词.在Cannabidiol中使用.结肠直肠癌是什么意思

更多相关视频

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...